Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ocular tissue" refers broadly to the various specialized biological structures that make up the eye. These include multiple distinct anatomical and functional components such as the cornea, sclera, conjunctiva, iris, ciliary body/muscle, lens, trabecular meshwork, Schlemm’s canal, retina (including photoreceptors), optic nerve head and supporting vasculature. Each component consists of unique cell types performing specialized roles essential for vision—such as focusing light onto the retina for image formation; regulating intraocular pressure via aqueous humor production and drainage; providing structural support; protecting against injury; converting light into neural signals; and maintaining fluid balance within different compartments of the eye. Dysfunction in any part can lead to significant visual impairment or blindness through diseases like glaucoma (involving outflow pathway dysfunction), cataracts (lens opacification), corneal dystrophies or retinal degeneration. Because "ocular tissue" is an umbrella term rather than a discrete molecular target such as a receptor or enzyme—and encompasses many different cellular targets—it is not considered a therapeutic target itself but rather describes an organ system composed of numerous potential drug targets.[1][2][3][4][5][6] **Note:** There is something incorrect about using "Ocular tissue" as a therapeutic target name because it does not refer to any single molecule/receptor/protein/enzyme/transporter/etc., but instead denotes an entire group of diverse anatomical structures containing many possible molecular targets. For structured data extraction purposes related to drug discovery/targeting efforts at the molecular level ("receptor", "enzyme", etc.), this entry should be flagged as incorrect/incomplete/too broad.[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular tissue.